Canopy Growth Announces June 2021 Investor Conference Participation

Executives to share insight into how the Company’s strategic approach to unleashing the power of cannabis to improve lives is creating value for shareholders, consumers, employees, and the industry

May 28, 2021

SMITHS FALLS, ON — Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) (“Canopy Growth” or “the Company”) recently announced that it will have three Canopy Growth executives participating in upcoming investor conferences in June 2021.

David Culver, Vice President of International Government Relations, and Judy Hong, Vice President of Investor Relations and Competitive Intelligence, will participate in a fireside chat during the Piper Sandler 41st Annual Consumer Marketplace Conference on Thursday, June 3 at 2:30pm ET. During their sit down, they will be sharing insights into the path towards legalization, what the regulatory landscape could look like post-prohibition, and how Canopy is positioned to win in the U.S. market.

Additionally, Rade Kovacevic, President and Chief Product Officer, will be participating in a fireside chat at the Oppenheimer 21st Annual Consumer Growth and E-Commerce Conference on Tuesday, June 15 at 9:05am ET. During his fireside, Rade will discuss how Canopy Growth is leveraging its industry-leading consumer insights to drive innovation in product and brand development.

Both presentations will be conducted by live webcast and will be accessible through Canopy Growth’s website at A replay option will be available on the website for the 90 days following each presentation.



Niklaus Schwenker
Director, Communications

Judy Hong
Vice President, Investor Relations & Competitive Intelligence

Tyler Burns
Director, Investor Relations
855-558-9333 ext. 122




About Canopy Growth Corporation

Canopy Growth (TSX:WEED,NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional federally-permissible CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information visit


Notice Regarding Forward Looking Statements

This press release contains “forward-looking statements” and “forward-looking information” within the meaning of applicable U.S. and Canadian securities laws (collectively, “forward-looking statements”), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use

of such terms and phrases as “intend,” “goal,” “strategy,” “estimate,” “expect,” “project,” “projections,” “forecasts,” “plans,” “seeks,” “anticipates,” “potential,” “proposed,” “will,” “should,” “could,” “would,” “may,” “likely,” “designed to,” “foreseeable future,” “believe,” “scheduled” and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward‐looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward‐looking statements and the forward‐looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation (“Canopy”) can be found under the section entitled “Risk Factors” in Canopy’s Annual Report on Form 10-K for the year ended March 31, 2020, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at and, respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward‐looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward‐ looking statement. Readers are cautioned not to put undue reliance on any forward‐looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.